These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 6229371)
1. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus. Alcocer-Varela J; Laffon A; Alarcón-Segovia D Clin Exp Immunol; 1984 Jan; 55(1):125-32. PubMed ID: 6229371 [TBL] [Abstract][Full Text] [Related]
3. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus. Sierakowski S; Kucharz EJ Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032 [TBL] [Abstract][Full Text] [Related]
4. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens. Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744 [TBL] [Abstract][Full Text] [Related]
5. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275 [TBL] [Abstract][Full Text] [Related]
6. Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma. Alcocer-Varela J; Martinez-Cordero E; Alarcon-Segovia D Clin Exp Immunol; 1985 Mar; 59(3):666-72. PubMed ID: 3872755 [TBL] [Abstract][Full Text] [Related]
7. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells. Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769 [TBL] [Abstract][Full Text] [Related]
8. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). Linker-Israeli M; Bakke AC; Kitridou RC; Gendler S; Gillis S; Horwitz DA J Immunol; 1983 Jun; 130(6):2651-5. PubMed ID: 6222112 [TBL] [Abstract][Full Text] [Related]
9. Defective production of interleukin-1 and tumour necrosis factor-alpha by stimulated monocytes from patients with systemic lupus erythematosus. Mũzes G; Vien CV; González-Cabello R; Fehér J; Gergely P Acta Med Hung; 1989; 46(4):245-52. PubMed ID: 2636360 [TBL] [Abstract][Full Text] [Related]
10. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411 [TBL] [Abstract][Full Text] [Related]
11. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. Sagawa A; Abdou NI J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952 [TBL] [Abstract][Full Text] [Related]
12. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Kanda N; Tsuchida T; Tamaki K Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928 [TBL] [Abstract][Full Text] [Related]
13. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163 [TBL] [Abstract][Full Text] [Related]
14. Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus. Linker-Israeli M; Quismorio FP; Horwitz DA J Rheumatol; 1988 Aug; 15(8):1216-22. PubMed ID: 2972835 [TBL] [Abstract][Full Text] [Related]
15. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus. Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941 [TBL] [Abstract][Full Text] [Related]
16. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE). Morimoto C Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583 [TBL] [Abstract][Full Text] [Related]
17. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro. Volk HD; Diamantstein T Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381 [TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction. Alcocer-Varela J; Alarcon-Segovia D; Abud-Mendoza C Clin Exp Immunol; 1985 Apr; 60(1):31-8. PubMed ID: 3159524 [TBL] [Abstract][Full Text] [Related]
19. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus. Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124 [TBL] [Abstract][Full Text] [Related]
20. Production and release of IL-1 beta by human peripheral blood monocytes in response to diverse stimuli: possible role of "microdamage" to account for unregulated release. Jessop JJ; Hoffman T Lymphokine Cytokine Res; 1993 Feb; 12(1):51-8. PubMed ID: 8457632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]